Android

From WikiMD's WELLNESSPEDIA

Mobile operating system developed by Google


Android is a mobile operating system based on a modified version of the Linux kernel and other open source software, designed primarily for touchscreen mobile devices such as smartphones and tablet computers. Android is developed by a consortium of developers known as the Open Handset Alliance, with the main contributor and commercial marketer being Google.

History[edit]

Android was unveiled in 2007, with the first commercial Android device, the HTC Dream, being launched in September 2008. The operating system has since gone through multiple major releases, with the latest version being Android 12, released in October 2021.

Features[edit]

Android's user interface is mainly based on direct manipulation, using touch gestures that loosely correspond to real-world actions, such as swiping, tapping, pinching, and reverse pinching to manipulate on-screen objects. Internal hardware such as accelerometers, gyroscopes, and proximity sensors are used by some applications to respond to additional user actions, for example adjusting the screen from portrait to landscape depending on how the device is oriented.

Applications[edit]

Android has a large community of developers writing applications ("apps") that extend the functionality of the devices. Developers write primarily in a customized version of the Java language. There are over three million apps available for Android in the Google Play store.

Security[edit]

Android's security features include a robust sandboxing model, application permissions, and encryption. Google also provides regular security updates to the operating system.

Versions[edit]

Android versions are released under a code name and are in alphabetical order. Some of the notable versions include:

Market Share[edit]

Android is the most widely used mobile operating system in the world, with a significant market share in many countries. It is particularly dominant in regions such as Asia, South America, and Africa.

See Also[edit]

References[edit]


External Links[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.